NSERC awards funding for General Fusion LM26 diagnostic system 13-11-2024, 21:00

Duck Creek partners with Suncorp to deliver a suite of cloud-native, low-code core insurance delivery solutions 3-12-2024, 04:00

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26